Product Images Fluovix Plus

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 5 images provide visual information about the product associated with Fluovix Plus NDC 72275-718 by Primary Pharmaceuticals, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

label - fluovixPLUS

label - fluovixPLUS

The text provides instructions on the application of Fluovix Plus, which contains Fluacinonide 0.19% cream (120gm - 1 Tube), 100% Soft Silicone (1.59 "x 58" - 1 Roll), and Self-Adherent Wrap (1" x 180" - 1 Roll). The package contains a warning to keep the container tightly closed and out of reach of children. It also notes that accompanying inserts for each item enclosed provide full prescribing information. The text includes steps for applying the silicone tape and guidelines to be followed.*

Table 1 - image 01

Table 1 - image 01

This is a table showing the most commonly observed adverse reactions in adult clinical trials for Fluocinonide cream when applied once or twice daily. The adverse reactions are listed with their rate of occurrence in percentages for each application frequency and compared to the vehicle cream. The safety of using Fluocinonide cream in patients between 12 to 17 years old was similar to that observed in adults.*

Chemical Structure - image 02

Chemical Structure - image 02

Table 2 - image 03

Table 2 - image 03

This is a table comparing the efficacy of fluocinonide in plaque-type psoriasis in adults using different vehicle applications and frequencies. The table provides the number of subjects in each treatment group, as well as the percentage of subjects achieving treatment success, defined as being cleared or almost cleared. However, there seems to be some garbled text and non-English characters in the table that may have resulted from errors.*

Table 3 - image 04

Table 3 - image 04

This is a table showing the effectiveness of two topical vehicles, Flugrcejr;flide, and Flugfér;flide, in treating atopic dermatitis in adults. The table presents the number of subjects who achieved treatment success or were cleared after using the two vehicles daily for a certain period. The percentage of subjects who achieved treatment success was higher with Flugrcejr;flide administered once daily (59%) compared to Flugfér;flide administered twice daily (57%). The table also mentions that some subjects were cleared or almost cleared after treatment.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.